A similar study in 1316 patients with chronic kidney disease also showed that FABP4 levels, ascertained using the multiplex proximity extension assay (PEA) technique [56], were associated with secondary major cardiovascular events (MACE); however, this could not be replicated in a cohort of 300 patients [57]. This evidence concerns the gene FABP4 and chronic kidney disease.